» Articles » PMID: 35909567

Association Between Diabetic Retinopathy and Insomnia Risk: A Nationwide Population-Based Study

Overview
Specialty Endocrinology
Date 2022 Aug 1
PMID 35909567
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous studies have suggested a close link between sleep disturbances and diabetic retinopathy (DR). However, to date, no confirmatory findings have been reported. We aimed to explore the risk of insomnia in DR by considering demographic factors and diabetes mellitus (DM)-related variables.

Methods: A nationwide population-based cohort of 2,206,619 patients with type 2 diabetes from the Korean National Insurance Service Database was followed up for insomnia incidence. DR, non-proliferative DR (NPDR), and proliferative DR (PDR) were defined according to ICD-10 codes. The interactive effects of sex, age, and DM-related variables were analyzed to evaluate their impact on insomnia risk in DR.

Results: Compared with the non-DR group, insomnia risk was increased in the DR [(adjusted hazard ratio (aHR): 1.125, 95% confidence interval (CI):1.108-1.142), NPDR (aHR:1.117, 95% CI:1.099-1.134), and PDR (aHR:1.205, 95% CI: 1.156-1.256), even after controlling for comorbidities, lifestyle factors, and DM-related variables. The men and youngest age groups (<40 years) were most vulnerable to insomnia risk. Sex, age, DM duration, and chronic kidney disease (CKD) status exerted interactive effects with DR status in increasing the insomnia risk. In the PDR group, sex, age, DM duration, insulin therapy status, and CKD status exerted interactive effects that increased the risk of insomnia.

Conclusion: Insomnia risk is significantly higher in patients with DR, and clinical attention is warranted.

Citing Articles

Variations in Electronic Health Record-Based Definitions of Diabetic Retinopathy Cohorts: A Literature Review and Quantitative Analysis.

Chen J, Copado I, Vallejos C, Kalaw F, Soe P, Cai C Ophthalmol Sci. 2024; 4(4):100468.

PMID: 38560278 PMC: 10973665. DOI: 10.1016/j.xops.2024.100468.


Multidimensional sleep health and diabetic retinopathy: Systematic review and meta-analysis.

Simonson M, Li Y, Zhu B, McAnany J, Chirakalwasan N, Vajaranant T Sleep Med Rev. 2023; 74:101891.

PMID: 38118339 PMC: 10963161. DOI: 10.1016/j.smrv.2023.101891.

References
1.
Noh J, Han K, Ko S, Ko K, Park C . Trends in the pervasiveness of type 2 diabetes, impaired fasting glucose and co-morbidities during an 8-year-follow-up of nationwide Korean population. Sci Rep. 2017; 7:46656. PMC: 5397969. DOI: 10.1038/srep46656. View

2.
Obara E, Hannibal J, Heegaard S, Fahrenkrug J . Loss of Melanopsin-Expressing Retinal Ganglion Cells in Patients With Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2017; 58(4):2187-2192. DOI: 10.1167/iovs.16-21168. View

3.
Ligda G, Ploubidis D, Foteli S, Kontou P, Nikolaou C, Tentolouris N . Quality of life in subjects with type 2 diabetes mellitus with diabetic retinopathy: A case-control study. Diabetes Metab Syndr. 2019; 13(2):947-952. DOI: 10.1016/j.dsx.2018.12.012. View

4.
Tan L, Chen P, Chiang H, King E, Yeh H, Hsiao Y . Insomnia and Poor Sleep in CKD: A Systematic Review and Meta-analysis. Kidney Med. 2022; 4(5):100458. PMC: 9065912. DOI: 10.1016/j.xkme.2022.100458. View

5.
Nuzzi R, Scalabrin S, Becco A, Panzica G . Gonadal Hormones and Retinal Disorders: A Review. Front Endocrinol (Lausanne). 2018; 9:66. PMC: 5840201. DOI: 10.3389/fendo.2018.00066. View